|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0011777,
umls-concept:C0013216,
umls-concept:C0027498,
umls-concept:C0035820,
umls-concept:C0061851,
umls-concept:C0065818,
umls-concept:C0205178,
umls-concept:C0205390,
umls-concept:C0205421,
umls-concept:C0220825,
umls-concept:C0442796,
umls-concept:C0678226,
umls-concept:C1707455,
umls-concept:C1708528,
umls-concept:C1881878
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1997-9-8
|
|
pubmed:abstractText |
To compare the efficacy of dolasetron and ondansetron in controlling nausea and vomiting in the first 24 hours; to evaluate the efficacy when dexamethasone is added to either drug in the first 24 hours; and to extend these comparisons over 7 days in patients receiving moderately emetogenic chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:ChinCC,
pubmed-author:DempseyEE,
pubmed-author:GuevinR MRM,
pubmed-author:HainsworthJJ,
pubmed-author:HoskinsPP,
pubmed-author:KrookJ EJE,
pubmed-author:LoftersW SWS,
pubmed-author:MoquinJ PJP,
pubmed-author:NavaraJJ,
pubmed-author:PalmerMM,
pubmed-author:PaterJ LJL,
pubmed-author:VermaSS,
pubmed-author:WaldeDD,
pubmed-author:WilsonKK,
pubmed-author:ZehEE
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2966-73
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9256141-Administration, Oral,
pubmed-meshheading:9256141-Antiemetics,
pubmed-meshheading:9256141-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9256141-Dexamethasone,
pubmed-meshheading:9256141-Double-Blind Method,
pubmed-meshheading:9256141-Drug Therapy, Combination,
pubmed-meshheading:9256141-Female,
pubmed-meshheading:9256141-Humans,
pubmed-meshheading:9256141-Indoles,
pubmed-meshheading:9256141-Injections, Intravenous,
pubmed-meshheading:9256141-Male,
pubmed-meshheading:9256141-Middle Aged,
pubmed-meshheading:9256141-Nausea,
pubmed-meshheading:9256141-Ondansetron,
pubmed-meshheading:9256141-Premedication,
pubmed-meshheading:9256141-Quality of Life,
pubmed-meshheading:9256141-Quinolizines,
pubmed-meshheading:9256141-Vomiting
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy.
|
|
pubmed:affiliation |
Kingston Regional Cancer Centre, and National Cancer Institute of Canada Clinical Trials Group, Ontario.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
